Jordan JFDA Medical Device Registry Analysis: Importer Concentration

A comprehensive, data-driven analysis of the Jordan Food and Drug Administration (JFDA) medical device registry. Analyze applicant volumes, major distributors, and warehouse allocations.

Executive Summary

What does the Jordan Food and Drug Administration (JFDA) medical device database reveal about market concentration among local importers (applicants) and major product categories?

An analysis of the 9,244 records in the Jordan JFDA database shows that the market is highly distributed but led by a few major distributors. Petra Drug Store leads all local applicants with 2.66% of the registry (246 registrations), acting as the local importer for major global brands like Ethicon (Johnson & Johnson), Smith & Nephew, and Grifols. Sukhtian Household & Toiletries Manufacturing Co. is the second largest applicant with 209 registrations. There are 918 unique applicants and 7,415 unique products registered in the database, indicating a highly active market with low manufacturer-side consolidation.

Introduction to the Jordan Medical Device Market

Jordan represents one of the most stable and advanced healthcare landscapes in the Levant region. The country boasts a high concentration of premium hospital facilities, such as the King Hussein Cancer Center and multiple private specialty clinics in Amman, making it a lucrative destination for advanced medical technology.

The market is regulated by the Jordan Food and Drug Administration (JFDA), established in 2003 as the sole national authority overseeing the quality, efficacy, and safety of food, drugs, cosmetics, and medical devices. To register and commercialize products in Jordan, foreign manufacturers must navigate the JFDA Medical Device Enquiry system.

To help regulatory affairs managers, market intelligence specialists, and commercial directors understand this market, MedDeviceGuide has performed a comprehensive, database-level analysis of the JFDA medical device registry based on the latest extract dated June 22, 2026. This article outlines the quantitative relationships in the database, maps out the major applicant organizations holding registrations, and analyzes the structure of Jordan's distribution channels and warehouse networks.

Understanding these parameters allows manufacturers to answer key operational questions: Which local drug stores and importers hold the most active JFDA registrations? How concentrated is the importer market among premium distributors, and which warehouses anchor Jordan's distribution network? Which global medtech brands and product categories dominate the registry? Below, we explore these database metrics to provide actionable intelligence for medtech market access.

Understanding the JFDA Regulatory Framework

The JFDA operates a risk-based classification system for medical devices, matching the global GHTF/IMDRF models:

Class I (Low Risk): Non-sterile bandages, examination lights, and basic surgical tools.
Class IIa (Moderate Risk): Hypodermic needles, dental alloys, and diagnostic ultrasound devices.
Class IIb (Moderate-to-High Risk): Infusion pumps, anesthesia machines, and diagnostic X-ray units.
Class III (High Risk): Coronary stents, pacemakers, heart valves, and orthopedic joint replacements.

All medical devices imported into Jordan must be registered with the JFDA. To initiate registration, a foreign manufacturer must appoint a local Authorized Representative (AR) who acts as the primary license holder (referred to as the "Applicant" in the registry database).

Currently, Jordan is utilizing Good Reliance Practices (GRelP). Under this framework, the JFDA accelerates the review timeline for devices that have already obtained marketing authorization from trusted reference authorities (such as the US FDA, EU Notified Bodies, Health Canada, or Japan PMDA). Utilizing a reference approval allows manufacturers to bypass local laboratory testing requirements in many cases, shortening the approval cycle to 4 to 8 months.

Quantitative Analysis of the JFDA Database

Our extraction of the JFDA medical device registry contains a total of 9,244 registered records. Below, we break down the high-level statistics of this dataset:

Total Active Registrations: 9,244
Unique Local Applicants (Importers): 918
Unique Registered Products: 7,415
Unique Registered Warehouses: 907

These figures show that the Jordan medtech market is highly fragmented at the applicant level. With 918 unique applicants, there is a large number of boutique medical distributors, specialized dealers, and local agents competing for commercial representation. However, when we analyze the volume of registrations held by these applicants, we observe a significant concentration of market listings among a select group of premium drug stores and logistics conglomerates.

The Leading Medical Device Applicants in Jordan

In Jordan, medical distributors are traditionally registered as "Drug Stores" under the Ministry of Health and the JFDA. These drug stores maintain the necessary pharmaceutical and medical device warehouses authorized to store and distribute temperature-controlled or sterile items.

The top 15 local applicants hold a combined 1,939 active registrations, representing 20.98% of the entire registry:

Rank	Local Applicant Name	Active Listings	Percentage of Database	Primary Brands Represented
1	Petra Drug Store	246	2.66%	Ethicon (J&J), Smith & Nephew, Grifols, Bausch & Lomb
2	Household & Toiletries Mfg. Co. (Sukhtian)*	209	2.26%	Sukhtian diagnostics, local personal care, basic IVDs
3	AL EIMAN DRUG STORE CO LLC	170	1.84%	Global anesthesia and intensive care brands
4	Reda Jardaneh Drug Store	162	1.75%	Specialized orthopedics, surgical suturing systems
5	Sabbagh Drug Store	152	1.64%	Consumables, general diagnostics, wound care
6	Professional Med Services Co.**	133	1.44%	Surgical instruments, high-value clinical hardware
7	Specialists Marketing & Trade***	116	1.25%	Cardiovascular products, laboratory reagents
8	Nakheel Est. for Medical Supplies****	108	1.17%	Clinical consumables, rehabilitation equipment
9	Al Wafi Drug Store	105	1.14%	Disposables, local hospital supplies, basic diagnostics
10	Jordanian Co for Marketing Int'l Brands*****	104	1.13%	In vitro diagnostics, point-of-care kits
11	Abu Sheikha Drug Store	98	1.06%	Hospital consumables, general medical supplies
12	Sukhtian Group	94	1.02%	Diagnostics, surgical disposables, personal care
13	Al-Dhahira Smart Solutions******	84	0.91%	Medical equipment and healthcare logistics
14	INTERBRANDS	81	0.88%	Multinational device brands, diagnostics
15	ORIENT DRUG STORE CO	77	0.83%	Pharmaceuticals, medical disposables

*Listed in Arabic database as: -شركة صناعة مستحضرات التجميل والمواد الكيماوية المنزلية - سختيان **Listed in Arabic database as: شركة المهنيون للخدمات والتوريدات الطبية الاردنية ***Listed in Arabic database as: المختصون للتسويق و التجارة ****Listed in Arabic database as: مؤسسة النخيل للمستلزمات الطبية *****Listed in Arabic database as: الشركة الاردنية لتسويق وتوزيع الاصناف العالمية ******Listed in Arabic database as: شركة الظاهرة الذكية للحلول والاعمال المتفوقة

Jordan Top Applicant Registry Share (Top 5):
Petra Drug Store: [======================] 246
Sukhtian Mfg Co:  [==================] 209
Al Eiman Drug:    [===============] 170
Reda Jardaneh:    [==============] 162
Sabbagh Drug:     [============] 152

Top Applicant Spotlight: Petra Drug Store

Petra Drug Store is the largest medical device license holder in Jordan, with 246 active records (2.66%). Established in Amman, Petra acts as the local importer and representative for major multinational device manufacturers. A deep-dive into Petra’s product registry reveals an extensive portfolio of premium clinical lines:

Wound Care & Orthopedics: Smith & Nephew (Allevyn, Acticoat, Algisite dressings; Versabond bone cement).
Surgical Suture & Implants: Ethicon (Vicryl, Monocryl, Stratafix sutures; Proceed mesh; Bone Wax).
Ophthalmology & Diagnostics: Bausch & Lomb surgical systems, Topcon ophthalmic devices, and Grifols transfusion/immunology systems (Leucored blood filter bags).

Partnering with a dominant distributor like Petra offers immediate access to the Royal Medical Services (RMS) and Ministry of Health (MOH) public tenders, but manufacturers must ensure their products receive adequate sales priority within such a large commercial catalog.

Sukhtian: Local Hybrid Manufacturing

The second-largest applicant is Sukhtian Household & Toiletries Manufacturing Co. (209 entries). Sukhtian is a prominent Jordanian conglomerate that operates both domestic manufacturing facilities (producing hygiene, cosmetics, and basic diagnostic products) and a distribution arm that imports specialized medical equipment. Sukhtian’s presence highlights the dual nature of Jordan’s market, where local manufacturing is rising in basic categories while advanced medtech remains imported.

Top Registered Medical Products in Jordan

The JFDA database features 7,415 unique product names, ranging from general medical consumables to high-risk cardiovascular systems. Analyzing the frequency of specific registrations reveals the products with the highest density of listings in Jordan:

ENDEAVOR RESOLUTE DES System (32 registrations): Medtronic’s coronary drug-eluting stent (DES) platform leads the database, reflecting the high clinical priority of cardiovascular medicine in Jordan and the competitive positioning of various stent configurations registered to cover distinct vessel sizes and delivery systems.
Stypcel Absorbable Hemostat (18 registrations): Reflects the high volume of surgical procedures performed in Amman's specialized cardiac and general surgery theaters.
Silverlon Antimicrobial Silver Wound Pad (10 registrations): High-density listing for advanced burns and surgical wound care.
Capio Sutures Polypropylene Non-Absorbable (10 registrations): Boston Scientific’s specialized suturing device for pelvic floor reconstruction.
Biocare DX Cream (10 registrations): Skin barrier and clinical dermatological device.

The dominance of cardiovascular devices and surgical consumables among the top product listings reflects where Jordan's health system allocates the most budget. Public procurement via joint tenders regularly prioritizes these therapeutic areas.

JFDA Good Reliance Practices (GRelP) Guidelines

The JFDA's adoption of the Good Reliance Practices (GRelP) guideline has redefined the regulatory pathway for foreign manufacturers. Under GRelP, JFDA recognizes that clinical and technical evaluations performed by reference authorities do not need to be duplicated.

Reference Jurisdictions and Dossier Adjustments

To benefit from the reliance pathway, the manufacturer must provide proof of market authorization in at least one of the following reference regions:

United States (US FDA): 510(k) clearance letter, PMA approval letter, or De Novo classification order.
European Union (CE Mark under EU MDR/IVDR): Valid Certificate of Conformity issued by an EU Notified Body.
Japan (PMDA): Marketing authorization approval.
Canada (Health Canada): Active Medical Device License (MDL).
Australia (TGA): Australian Register of Therapeutic Goods (ARTG) listing.

If a reference approval is present, the JFDA dossier is adjusted:

Biocompatibility Data: Local testing is waived if the CE Mark or FDA clearance is accompanied by the corresponding ISO 10993 evaluation report.
Sterilization Validation: Accepted on face value based on reference certificates.
Clinical Evaluation: The technical review focuses on verifying that the clinical indications approved by the reference authority match the indications requested for Jordan.

For devices without a reference approval (e.g., direct imports from non-recognized jurisdictions), the JFDA conducts a full, un-reliant evaluation, which regularly requires sending product samples to the JFDA laboratory in Amman, extending the review timeline by 6 to 12 months.

Local Importer concentration and Warehouse Network

Jordanian regulations dictate that a registered applicant must possess a warehouse facility certified for Good Storage Practices (GSP) and audited by the JFDA. This requirement ensures that medical products—especially sterile implants and temperature-controlled IVD reagents—are stored in compliance with manufacturer specifications.

Our warehouse registry analysis shows a near 1-to-1 match with applicant listings, indicating that almost all registered applicants operate their own logistics centers:

Total Registered Warehouses: 907
Petra Warehouse (مستودع البتراء للمواد الطبية): 246 records (2.66% of warehouse-allocated listings)
Sukhtian Warehouse (شركة صناعة مستحضرات التجميل والمواد الكيماوية المنزلية - سختيان): 209 records (2.26%)
Jordanian Co for Marketing Int'l Brands (الشركة الاردنية لتسويق وتوزيع الاصناف العالمية): 185 records (2.00%)
Al Eiman Warehouse (شركة مستودع أدوية الإيمان ذ م م): 170 records (1.84%)

Warehouse Record Distribution (Top 5):
Petra Warehouse:     [========================] 246
Sukhtian Warehouse:  [====================] 209
Jor Marketing Whse:  [==================] 185
Al Eiman Whse:       [================] 170
Reda Jardaneh Whse:  [===============] 162

For foreign manufacturers, evaluating a distributor's warehouse capacity, cold chain logistics, and secondary packaging capabilities is just as critical as analyzing their sales force. Under JFDA regulations, if a distributor’s warehouse license is suspended due to a quality violation, all associated medical device registrations are frozen, preventing importation.

Long-Tail Distribution Dynamics

While the top 15 applicants control roughly 21% of the registry, the remaining registrations are spread across more than 900 smaller importers, giving Jordan one of the most fragmented medical device distribution bases in the MENA region. The median applicant holds only a handful of listings, meaning most local representatives operate as niche specialists focused on a single therapeutic area (such as dental consumables, ophthalmology, or rehabilitation equipment) rather than full-line distributors.

Distributor Profile	Typical Registration Footprint	Best-Fit Manufacturer
Full-line drug store (e.g., Petra, Al Eiman)	150+ registrations across multiple specialties	Multi-portfolio firms seeking broad hospital access and public tender eligibility
Mid-tier specialty distributor	40–120 registrations in a focused area	Manufacturers with a strong single-specialty pipeline (e.g., cardiology, IVD)
Boutique importer	Under 40 registrations, niche focus	Early-stage or single-product entrants needing dedicated commercial attention

Foreign manufacturers should weigh breadth against attention: a top-tier partner delivers immediate reach into Royal Medical Services and Ministry of Health tenders, but a specialized mid-tier distributor often provides sharper clinical selling for high-complexity Class III implants that require surgeon training and ongoing technical support. Mapping a target distributor's current JFDA portfolio, warehouse license status, and recent Joint Procurement Department tender wins against your product's therapeutic area is the most reliable way to forecast post-registration commercial performance in Jordan.

Jordan JFDA Medical Device Pricing Regulations and Tenders

A unique feature of the Jordanian medical device market is the JFDA's direct role in price regulation. Unlike many markets where price controls apply only to pharmaceuticals, the JFDA regulates the public and private sector prices for specific high-volume, high-value medical items:

Cardiac Stents and Catheters: Subject to fixed price ceilings to protect patients from excessive out-of-pocket costs.
Ophthalmic Lenses and Viscoelastic Solutions: Regulated under the ophthalmology pricing guidelines.
Wound Care and Dressings: Price-controlled when designated for use under public insurance schemes.

Joint Procurement via the Joint Procurement Department (JPD)

The Jordanian government utilizes the Joint Procurement Department (JPD) to purchase medical devices, IVDs, and pharmaceuticals for all public health entities, including:

The Ministry of Health (MOH) hospitals.
The Royal Medical Services (RMS) military hospitals.
The King Abdullah University Hospital (KAUH).
The Jordan University Hospital (JUH).

To participate in JPD tenders, the device must be registered with the JFDA. Having an active registration certificate held by a reputable LTR (like Petra or Al Eiman) with a proven track record of successful tender administration is the single most critical factor in securing high-volume public procurement contracts.

Step-by-Step Pathway to JFDA Registration

For manufacturers entering the Jordanian market, the registration process requires close coordination with the local representative. While a detailed process overview is available in our companion Jordan JFDA registration guide, the general workflow follows this sequence:

graph TD
    A[Appoint Jordan Local Authorized Representative - Drug Store] --> B[Prepare JFDA Dossier in English/Arabic]
    B --> C[Obtain Legalized CFS and CE/FDA Certificates]
    C --> D[Submit Dossier via JFDA e-Portal]
    D --> E[Pay JFDA Registration and Evaluation Fees]
    E --> F{Does the Device Require Local Lab Testing?}
    F -->|Yes| G[Send Product Samples to JFDA Laboratory]
    F -->|No| H[JFDA Technical Dossier Evaluation]
    G --> H
    H --> I{Are there Technical Queries?}
    I -->|Yes| J[Provide Clarifications within 60 Days]
    I -->|No| K[Issue JFDA Registration Certificate: 5 to 10 Years]
    J --> H
    K --> L[Apply for JFDA Import Permit for Shipments]

Select and Authorize the Drug Store: Execute an Authorized Representative contract and issue a Power of Attorney (PoA), which must be legalized by the Jordan Embassy in the manufacturer's country.
Dossier Compilation: Assemble technical files including:
- Certificate of Free Sale (CFS) from the country of origin.
- Declaration of Conformity (DoC).
- ISO 13485 certificate.
- Quality manual and manufacturing process charts.
- Device packaging artwork and bilingual (Arabic/English) instructions for use (IFU).
- Biocompatibility, sterilization validation, and shelf-life data.
- Clinical evaluation reports.
Submission via JFDA Portal: The local drug store uploads the files through the JFDA electronic submission system and pays the applicable evaluation fees.
Testing (If Applicable): Certain high-risk Class III devices or IVD reagents may require sample testing at the JFDA Central Laboratory in Amman to verify performance specifications.
Technical Dossier Review: The JFDA medical device committee evaluates the dossier. Deficiencies or queries must be answered within a designated timeline (typically 60 days).
Approval & Import Control: Upon approval, JFDA issues the registration certificate (valid for 5 to 10 years). The importer must apply for an import permit for each commercial batch imported.

Regional Comparison: Jordan JFDA vs. Saudi Arabia SFDA vs. UAE MOH

Jordan operates within the broader Middle East and North Africa (MENA) regulatory landscape. Its requirements are highly aligned with neighboring Gulf Cooperation Council (GCC) regulators, though notable differences in fees, review timelines, and reliance pathways exist.

The table below provides a comparison between Jordan, Saudi Arabia, and the United Arab Emirates:

Parameter	Jordan (JFDA)	Saudi Arabia (SFDA)	United Arab Emirates (MOHAP)
National Authority	Jordan Food and Drug Administration	Saudi Food and Drug Authority	Ministry of Health and Prevention
Market Size	Levant Hub (High Quality, Low Volume)	GCC Leader (High Value, High Volume)	GCC Innovation Hub (Rapid Access)
Local Rep Requirement	Yes (Licensed Drug Store/AR)	Yes (Saudi Authorized Representative)	Yes (UAE Licensed Importer/AR)
Reliance Pathway?	Yes (Good Reliance Practices - GRelP)	Yes (MDMA Medical Device Marketing Authorization)	Yes (Fast-track for FDA/CE cleared devices)
Average Registration Fee	Moderate ($500 - $1,500)	High ($3,000 - $7,000+)	Moderate-to-High ($1,500 - $3,000)
Typical Approval Timeline	4 to 8 Months	3 to 6 Months	3 to 6 Months
Language Requirements	English (Technical), Arabic/English (IFU)	English (Technical), Arabic/English (IFU)	English (Technical), Arabic/English (IFU)

Strategic Takeaways for Medtech Exporters

Leverage Reliance Pathways: Always present FDA clearance or EU CE mark documentation. Utilizing JFDA's Good Reliance Practices (GRelP) is the fastest way to bypass technical dossier backlogs and skip local laboratory sample testing.
Evaluate Importer Portfolios: When selecting a local partner, analyze their JFDA registry footprint. A distributor like Petra Drug Store offers established access to hospitals, but a mid-sized, specialized distributor might provide better focus for niche therapeutic platforms.
Audit the Warehouse Capability: Since Jordanian regulations tie product registrations directly to the physical warehouse site, ensure your distributor's storage facilities have passed JFDA audits for Good Storage Practices (GSP).
Prepare for Bilingual Packaging: Ensure your product labeling and IFU are available in both Arabic and English. This is particularly critical for home-use devices and clinical consumables.

Frequently Asked Questions (FAQs)

How many unique medical device applicants are registered with the JFDA?

There are 918 unique applicants registered in the JFDA medical device database, showing a highly active and distributed distributor market. However, the top 10 applicants hold over 16% of all active registrations.

Which company is the largest distributor of medical devices in Jordan according to JFDA data?

Petra Drug Store is the largest distributor, holding 246 registrations (2.66% of the database) and representing major global brands like Ethicon (J&J), Smith & Nephew, and Grifols.

What is the typical validity of a JFDA medical device registration?

JFDA registrations are typically valid for 5 to 10 years, depending on the classification, country of origin, and whether the device is subjected to local laboratory evaluations.

Does Jordan require local clinical trials for medical device registration?

Generally, the JFDA does not require local clinical trials. It relies on clinical evaluation reports (CERs) containing data from trials conducted in Europe, the United States, or other reference jurisdictions, combined with post-market clinical follow-up (PMCF) data.

How is the language requirement handled for instructions for use (IFU) in Jordan?

Technical documentation must be in English. For clinical equipment used strictly by healthcare professionals, English IFUs are acceptable. For patient-use or home-use devices, the IFU must be translated into Arabic to ensure safe operation by the end user.

Sources and Database Metadata

Primary Dataset: Jordan Food and Drug Administration (JFDA) Medical Devices Public Enquiry Portal: https://services.jfda.jo/jfda/medicaldevices/mdenquiry.aspx
Official Regulator Website: JFDA Official Portal: http://www.jfda.jo/
Open Government Data Portal: Jordan Ministry of Digital Economy and Entrepreneurship Open Data: https://opendata.gov.jo/
Analysis Extract Date: June 22, 2026.
Total Analyzed Sample: 9,244 records across 918 applicants.

Disclaimer: The analytical findings and statistics presented in this report are based on the JFDA public enquiry portal extract dated June 22, 2026. They are intended for educational and strategic planning purposes only. Manufacturers must consult with the JFDA or their appointed legal representative to confirm current registration fees and specific regulatory pathways before pursuing market entry.